These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 3914252

  • 1. Levamisole treatment of recurrent spastic bronchitis in children--the effect on selected parameters of immunologic and hemostatic systems.
    Prusek W, Wieczorek E, Podwysocka M, Maćkowiak J.
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):803-9. PubMed ID: 3914252
    [Abstract] [Full Text] [Related]

  • 2. [Effect of levamisole on cellular immunity indices in chronic bronchitis and chronic pneumonia patients].
    Borisova AM, Novikova TA, Glazko AV.
    Ter Arkh; 1984; 56(10):29-31. PubMed ID: 6335306
    [Abstract] [Full Text] [Related]

  • 3. [State of cellular and humoral immunity in recurrent and chronic bronchopulmonary diseases in children before and after immunostimulation with levamisole].
    Błaszczyk E, Kulczyk BA.
    Wiad Lek; 1985 Apr 01; 38(7):495-9. PubMed ID: 3874484
    [No Abstract] [Full Text] [Related]

  • 4. Humoral and cellular immune mechanisms in children with spastic bronchitis.
    Prusek W, Wieczorek E, Podwysocka M, Agopsowicz T.
    Arch Immunol Ther Exp (Warsz); 1984 Apr 01; 32(2):167-76. PubMed ID: 6333227
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of immunocompetent cell subpopulations in chronic bronchitis patients during the use of different immunomodulating preparations].
    Karaulov AV, Sil'vestrov VP, Martsinovskiĭ VIu, Bulycheva NA, Likov VF.
    Ter Arkh; 1984 Apr 01; 56(10):14-7. PubMed ID: 6335305
    [Abstract] [Full Text] [Related]

  • 6. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus].
    Gandzha IM, Sakharchuk VM, Lysenko GI.
    Ter Arkh; 1981 Apr 01; 53(7):121-4. PubMed ID: 6457406
    [No Abstract] [Full Text] [Related]

  • 7. [Cellular and humoral indicators of the immunomodulating effect of levamisole in patients with lymphocytic leukemia].
    Tretiak NN, Koval' AI, Minchenko ZhN, Sverstiuk AE.
    Vrach Delo; 1985 Dec 01; (12):58-61. PubMed ID: 3879409
    [No Abstract] [Full Text] [Related]

  • 8. [Therapeutic trial with levamisole in recurrent obstructive bronchitis].
    Dragicevic G, Concha N, Valdés V.
    Rev Chil Pediatr; 1981 Dec 01; 52(4):327-31. PubMed ID: 7043669
    [No Abstract] [Full Text] [Related]

  • 9. [Evaluation of individual sensitivity to levamisole in children with asthmatic bronchitis].
    Askambaeva KA, Shafranova NG.
    Sov Med; 1990 Dec 01; (10):29-31. PubMed ID: 2293384
    [Abstract] [Full Text] [Related]

  • 10. The treatment of systemic lupus erythematosus (SLE) with the T-cell immunostimulant drug levamisole: A case report.
    Gordon BL, Keenan JP.
    Ann Allergy; 1975 Dec 01; 35(6):343-55. PubMed ID: 1081857
    [Abstract] [Full Text] [Related]

  • 11. [Levamisol in the treatment of recurrent urinary tract infections].
    Lubetkin AM, Remedi RF, Granero M, Brarda O.
    Bol Med Hosp Infant Mex; 1979 Dec 01; 36(6):1109-12. PubMed ID: 385017
    [Abstract] [Full Text] [Related]

  • 12. [Differentiated immunocorrective therapy of dust-induced bronchitis in machine builders].
    Kleĭner AI, Shmuter LM, Makotchenko VM, Efremova VA, Trukh VS.
    Gig Tr Prof Zabol; 1988 Aug 01; (8):19-21. PubMed ID: 3265399
    [No Abstract] [Full Text] [Related]

  • 13. Immunocompetent cells and lymphocyte reactivity to mitogens in levamisole-treated brain tumor children.
    Hajnzić TF, Kastelan M, Lukac J, Hajnzić T.
    Pediatr Hematol Oncol; 1999 Aug 01; 16(4):335-40. PubMed ID: 10407870
    [Abstract] [Full Text] [Related]

  • 14. [Effect of levamisole on the peripheral lymphocyte population (T and B lymphocytes) in 2 cases of chronic lymphocytic leukemia].
    Kaloustian E, Harousseau JL, Krulik M, Mougeot-Martin M, Brault JL, Debray J.
    Nouv Presse Med; 1977 Dec 31; 6(45):4208-9. PubMed ID: 305566
    [No Abstract] [Full Text] [Related]

  • 15. Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases.
    Verhaegen H, De Cree J, De Cock W, Verbruggen F.
    Clin Exp Immunol; 1977 Feb 31; 27(2):313-8. PubMed ID: 321165
    [Abstract] [Full Text] [Related]

  • 16. [E-RFC (T cells) and Ig-positive cells (B cells) in the peripheral blood of patients with lymphogranulomatosis and possible immunocorrection with levamisole].
    Markova TP, Danilova NV.
    Ter Arkh; 1985 Feb 31; 57(7):15-8. PubMed ID: 3876611
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic effectiveness of hemodes in patients with chronic bronchitis with drug allergy].
    Provotorov VM, Nikitin AV.
    Ter Arkh; 1986 Feb 31; 58(4):66-8. PubMed ID: 3520932
    [No Abstract] [Full Text] [Related]

  • 18. Some aspects of humoral and cellular immunity in children suffering from spastic bronchitis.
    Prusek W, Jankowski A.
    Arch Immunol Ther Exp (Warsz); 1980 Feb 31; 28(1):53-9. PubMed ID: 6968194
    [Abstract] [Full Text] [Related]

  • 19. [Effect of dekaris on the immunity indices of children with osteomyelitis].
    Samsygin SA, Dolgina EN, Mortina SV, Koniaeva OL.
    Pediatriia; 1984 Feb 31; (2):16-9. PubMed ID: 6609340
    [No Abstract] [Full Text] [Related]

  • 20. [Immunologic state and effect of long-term levamisole therapy on selected immunologic parameters in children with steroid sensitive nephrotic syndrome during remission].
    Prandota J, Jankowski A, Szozda A.
    Pol Tyg Lek; 1984 Feb 31; 48(20-22):455-9. PubMed ID: 8170809
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.